Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

622 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 622 results

Testing effectiveness (Phase 2)UnknownNCT00006114
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT00887458
What this trial is testing

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Who this might be right for
Prostate Cancer
Johns Hopkins University 46
Testing effectiveness (Phase 2)Study completedNCT01519414
What this trial is testing

Tivantinib in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)Study completedNCT03565835
What this trial is testing

Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Montefiore Medical Center 31
Not applicableStudy completedNCT04330716
What this trial is testing

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+1 more
Dana-Farber Cancer Institute 269
Not applicableUnknownNCT03948204
What this trial is testing

Quality of Life and Shared Decision Making in Prostate Cancer

Who this might be right for
Prostate Cancer
Norwegian Institute of Public Health 10,000
Early research (Phase 1)Ended earlyNCT02478125
What this trial is testing

Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Testing effectiveness (Phase 2)Ended earlyNCT03764540
What this trial is testing

Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide

Who this might be right for
Metastatic Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 57
Testing effectiveness (Phase 2)Looking for participantsNCT07336446
What this trial is testing

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

Who this might be right for
Prostate Cancer
AstraZeneca 300
Testing effectiveness (Phase 2)Study completedNCT02280317
What this trial is testing

Dose Finding Safety Study of VAL201 in Cancer Patients

Who this might be right for
Stage III Prostate CarcinomaStage IV Prostate Carcinoma
ValiRx Plc 12
Early research (Phase 1)Active Not RecruitingNCT06193993
What this trial is testing

Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerMetastatic CancerHormone Sensitive Prostate Cancer+1 more
National University Hospital, Singapore 10
Early research (Phase 1)Study completedNCT01949519
What this trial is testing

Docetaxel and Lycopene in Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Medical University of South Carolina 24
Early research (Phase 1)Not Yet RecruitingNCT06866795
What this trial is testing

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Geode Therapeutics Inc. 42
Testing effectiveness (Phase 2)Study completedNCT00004211
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 17
Testing effectiveness (Phase 2)Study completedNCT00045227
What this trial is testing

Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT02487823
What this trial is testing

Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer

Who this might be right for
Non Castrate Metastatic Prostate Cancer
Institut Paoli-Calmettes 6
Testing effectiveness (Phase 2)Looking for participantsNCT06480110
What this trial is testing

Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Rigshospitalet, Denmark 30
Testing effectiveness (Phase 2)Study completedNCT00020046
What this trial is testing

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT00392938
What this trial is testing

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

Who this might be right for
Metastatic CancerProstate Cancer
University of Washington 11
Not applicableLooking for participantsNCT01050504
What this trial is testing

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more
University of Washington 1,500
Next Page